Threat Of Adulteration For Profit Grows With Globalization Of Supply Chain
This article was originally published in The Tan Sheet
Executive Summary
Deliberate adulteration of dietary supplements for economic gain is a growing threat that FDA and the food and drug industries must work together to neutralize, according to the agency's food safety chief and a trade group executive
You may also be interested in...
U.S. FDA Enforcement Priorities Include Globalization Threats
U.S. FDA will overhaul its enforcement approach to reflect the impact of globalization by partnering more with foreign counterparts, streamlining inspections, recalls and emergency responses and using stiff criminal sanctions to deter noncompliance, agency officials say.
FDA Enforcement Priorities Include Globalization Threats
FDA will overhaul its enforcement approach to reflect the impact of globalization by partnering more with foreign counterparts, streamlining inspections, recalls and emergency responses and using stiff criminal sanctions to deter noncompliance, agency officials say.
FDA Enforcement Priorities Include Globalization Threats
FDA will overhaul its enforcement approach to reflect the impact of globalization by partnering more with foreign counterparts, streamlining inspections, recalls and emergency responses and using stiff criminal sanctions to deter noncompliance, agency officials say.